undamentalytics Newsletter
Sign in

China Pharma Holdings, Inc. balance sheet

At the end of fiscal 2025, China Pharma Holdings, Inc. had total assets of $31.0m, total liabilities of $8.3m and shareholders' equity of $22.7m. It held $345,112 in cash against $3.3m of debt: net debt of $3.0m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents444——632111521100
Receivables6270664514642111001000
Inventory20303625151076544334221
Total current assets921111138442241812965966322
Total assets132156163158121977960452221231816153145
Accounts payable53———————————————
Deferred revenue (current)—————————11010000
Total current liabilities13141512141310910101111137578
Short-term debt—————————————1112
Long-term debt———————97455—————
Total debt4455550974710113332
Total liabilities141415252824201715131317139789
Shareholders' equity11814214913393735943309864782336
Net debt (negative = net cash)0−01——−2−37536592231
Shares outstanding43m——44m———————24m————41m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: CPHI vs TXMDCPHI vs EYPTCPHI vs NTRB

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from China Pharma Holdings, Inc.'s SEC filings (10-K and 10-Q), retrieved October 31, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to China Pharma Holdings, Inc.